InsiderTrades

Form 4 for INCY Incyte

Accepted 2025-07-07 00:00:00 ET · period of report 2025-07-02 · accession 0000879169-25-000073 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-07-07 2025-07-02 INCY Denton Sheila A. EVP, GC M - OptEx $58.06 +599 27.1K +2% +$34.8K
D 2025-07-07 2025-07-02 INCY Denton Sheila A. EVP, GC S - Sale+OE $68.61 -599 26.5K -2% -$41.1K
D 2025-07-07 2025-07-02 INCY Denton Sheila A. EVP, GC M - OptEx $0.00 -599 16.2K -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-07-02 M A 599 $58.06 27,103 D — —
2 Common Common Stock 2025-07-02 S D 599 $68.61 26,504 D — — (F1) This includes an aggregate of 25,848 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
3 Derivative Employee Stock Option (right to buy) 2025-07-02 M D 599 $0.00 16,158 D $58.06 · — to 2033-10-02 599 Common Stock (F2) Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.